PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15564892-3	2004	The polymorphism in HTR2A (102T/C, -1438A/G) was identified by means of the polymerase chain reaction followed by restriction fragment length polymorphism, and the Fagerstrom Test for Nicotine Dependence was used to determine the extent of smoking behavior.	Nicotine	184-192	5-hydroxytryptamine receptor 2A	Homo sapiens	20-25	
22046326-8	2011	Overall, our results suggest that genetic variants potentially involved in nicotine metabolization (mainly, CYP2A6 polymorphisms) are those showing the strongest association with smoking-related phenotypes, as opposed to genetic variants influencing the brain effects of nicotine, e.g., through nicotinic acetylcholine (CHRNA5), serotoninergic (HTR2A), opioid (OPRM1) or cannabinoid receptors (CNR1).	Nicotine	75-83	5-hydroxytryptamine receptor 2A	Homo sapiens	345-350	
33541678-0	2021	5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.	Nicotine	70-78	5-hydroxytryptamine receptor 2A	Homo sapiens	0-6